Lidocaine Hydrochloride, Usp And D-glucose Monohydrate Structural Formula Images (Image 01)
Lidocaine Hydrochloride And Dextrose Injection, Solution
Product Images NDC 0338-0411
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride And Dextrose (NDC 0338-0411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lidocaine Hydrochloride Representative Container Label Ndc 0338-0411-02 (Image 02)
LOT EXP NDC 0338-0411-02 is a Lidocaine Hydrochloride and 5% Dextrose Injection USP containing 2 g per 250 mL (8 mg/mL). Each 100 mL of the sterile single dose container contains 800 mg Lidocaine HCI USP and 5 g Dextrose Hyprous USP with a pH of 4.0 (3.0 707.0) OsMOLARITY of 311 mOsmol/L (cac). The usual dosage is specified in the STK insert and it should not be used with supplementary medication other than a calibrated infusion device. The product can be stored in moisture barrier overwrap at room temperature (77°F or 25°C) until ready to use. The manufacturer is Baxter and it is meant for Rx only.*
Lidocaine Hydrochloride 0338-0411-02 Representative Carton Label (Image 03)
The text describes a lot number (T123456) and an expiration date (JAN 2020) for a medical product. The product is probably Lidocaine hydrochloride, with a concentration of 2g per 250mL, mixed with 5% dextrose in injection form. The code 280962 could refer to the product code.*
Lidocaine Hydrochloride Representative Container Label Ndc0338-0409-03 (Image 04)
This is a description of a drug called "Lidocaine Hydrochloride and 5% Dextrose Injection USP". It is available in a sterile single dose container with a volume of 500 mL. Each 100 mL of the injection contains 400 mg of Lidocaine HCI and 5 g of Dextrose Hyprous USP. The usual dosage information is available in the insert, and no supplementary medication should be added. It can only be used with a calibrated infusion device and should be stored at room temperature until ready to use. It is a prescription drug manufactured by Baxter.*
Lidocaine Hydrochloride Representative Carton Label 0338-0409-03 (Image 05)
This text appears to be a label of a medication called "5% Dextrose Injection, USP" with lot number T123456 and expiry date of January 2020. The label also shows the quantity per container (500mL) and a product code (280973). Not enough information is provided to determine the intended use or specific ingredients of this medication.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
